[go: up one dir, main page]

MX9202931A - COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN. - Google Patents

COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.

Info

Publication number
MX9202931A
MX9202931A MX9202931A MX9202931A MX9202931A MX 9202931 A MX9202931 A MX 9202931A MX 9202931 A MX9202931 A MX 9202931A MX 9202931 A MX9202931 A MX 9202931A MX 9202931 A MX9202931 A MX 9202931A
Authority
MX
Mexico
Prior art keywords
tropin
regulate
formation
compound
cell beta
Prior art date
Application number
MX9202931A
Other languages
Spanish (es)
Inventor
Michael Anthony Cawthorne
Anne Beloff-Chain
Original Assignee
Smithkline Beecham P L C Y Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P L C Y Co filed Critical Smithkline Beecham P L C Y Co
Publication of MX9202931A publication Critical patent/MX9202931A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
MX9202931A 1991-06-17 1992-06-17 COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN. MX9202931A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113038A GB9113038D0 (en) 1991-06-17 1991-06-17 Novel treatment and compositions

Publications (1)

Publication Number Publication Date
MX9202931A true MX9202931A (en) 1993-06-01

Family

ID=10696815

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202931A MX9202931A (en) 1991-06-17 1992-06-17 COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.

Country Status (10)

Country Link
EP (1) EP0671949A1 (en)
JP (1) JPH06508614A (en)
AU (2) AU2152392A (en)
CA (1) CA2111583A1 (en)
GB (1) GB9113038D0 (en)
IE (1) IE921964A1 (en)
MX (1) MX9202931A (en)
PT (1) PT100596A (en)
WO (1) WO1992022328A1 (en)
ZA (1) ZA924427B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus

Also Published As

Publication number Publication date
AU2152392A (en) 1993-01-12
WO1992022328A1 (en) 1992-12-23
CA2111583A1 (en) 1992-12-23
AU4449896A (en) 1996-05-02
PT100596A (en) 1993-08-31
JPH06508614A (en) 1994-09-29
EP0671949A1 (en) 1995-09-20
ZA924427B (en) 1993-06-23
IE921964A1 (en) 1992-12-30
GB9113038D0 (en) 1991-08-07

Similar Documents

Publication Publication Date Title
MX9203830A (en) PROCEDURE TO INCREASE THE OIL PRODUCTION OF OIL FIELDS.
NO854476L (en) THE STONE OF THE STOCK WALL.
FI852468L (en) ANGLE CONSTRUCTION OF THE CONSTRUCTION.
MX9203919A (en) PROCEDURE TO PURIFY ORGANOPOLISILOXANES.
MX9205637A (en) METHOD TO PREVENT THE REJECTION OF ALOINJERTOS.
DE3585137D1 (en) CRYSTALLINE CEPHALOSPORINANTIBIOTICS.
DE3382172D1 (en) BACTERIA-KILLING PYRIMIDINE COMPOUNDS.
FI850483L (en) SAETTING THE UTILIZATION OF CONTAINER CELLULOSAKOKOK.
IT8519897A0 (en) ORAL DOSAGE FORM OF ETOPOSIDE.
ITTO940823A0 (en) COMPOSITION TO REGULATE THE GROWTH OF INSECTS.
MX9202932A (en) COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.
MX9202931A (en) COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.
ES276569Y (en) COMPONABLE ELEMENTS FOR THE FORMATION OF FURNITURE
FI854268A0 (en) CRYSTALLINE AMINOMETHYLFOERENINGAR.
MX9204919A (en) PROCEDURE TO PRODUCE REFRIGERATION.
ES1017581Y (en) PALLETIZABLE STRUCTURE FOR THE FORMATION OF BOXES.
ES277361Y (en) KNOT FOR THE FORMATION OF SPACE STRUCTURES.
ES262364Y (en) STRUCTURE FOR THE FORMATION OF FURNITURE.
ES281324Y (en) STRUCTURE FOR THE FORMATION OF FURNITURE
ES1007026Y (en) STRUCTURE FOR THE FORMATION OF FURNITURE.
ES262582Y (en) "CANTONERA FOR THE FORMATION OF FURNITURE".
ES1019027Y (en) DETACHABLE STRUCTURE FOR FORMATION OF PARALLEL CYCLE SETS.
ES1005409Y (en) KNOT FOR THE FORMATION OF STRUCTURES FOR FURNITURE.
ES278795Y (en) STRUCTURE FOR THE FORMATION OF NICHES
ES284222Y (en) KNOT FOR THE FORMATION OF TUBULAR STRUCTURES, PARTICULARLY FOR THE CONSTRUCTION OF FURNITURE